{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T08:06:30Z","timestamp":1789632390599,"version":"build-2803163510"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Shanxi Basic Research Program","award":["202103021224363"],"award-info":[{"award-number":["202103021224363"]}]},{"name":"The Collaborative Innovation Fund of Medicine and Education of Jiangsu University","award":["JDY2023020"],"award-info":[{"award-number":["JDY2023020"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-026-05100-9","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T12:57:44Z","timestamp":1774270664000},"page":"4239-4251","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["MHC class II and PLA2R investigating the epitope presentation deficits driving antibody production in membranous nephropathy"],"prefix":"10.1007","volume":"58","author":[{"given":"Abdelhak","family":"Ouzaouit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenghua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haider Cuello","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Addai Frank","family":"Peprah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peilu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xunan","family":"Quan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingya","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"issue":"1","key":"5100_CR1","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1080\/0886022X.2021.1914655","volume":"43","author":"H Huang","year":"2021","unstructured":"Huang H et al (2021) Tacrolimus versus cyclophosphamide for patients with idiopathic membranous nephropathy and treated with steroids: a systematic review and meta-analysis of randomized controlled trials. Ren Fail 43(1):840\u2013850. https:\/\/doi.org\/10.1080\/0886022X.2021.1914655","journal-title":"Ren Fail"},{"issue":"1119","key":"5100_CR2","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1136\/postgradmedj-2018-135729","volume":"95","author":"KC Keri","year":"2019","unstructured":"Keri KC, Blumenthal S, Kulkarni V, Beck L, Chongkrairatanakul T (2019) Primary membranous nephropathy: comprehensive review and historical perspective. Postgrad Med J 95(1119):23\u201331. https:\/\/doi.org\/10.1136\/postgradmedj-2018-135729","journal-title":"Postgrad Med J"},{"issue":"2","key":"5100_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.nexres.2025.100345","volume":"2","author":"J Li","year":"2025","unstructured":"Li J et al (2025) Circulating anti-nephrin antibody as permeability factor for inducing primary focal segmental glomerular sclerosis and minimal change disease. Next Research 2(2):100345. https:\/\/doi.org\/10.1016\/j.nexres.2025.100345","journal-title":"Next Research"},{"issue":"4","key":"5100_CR4","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.semnephrol.2011.06.004","volume":"31","author":"SP Makker","year":"2011","unstructured":"Makker SP, Tramontano A (2011) Idiopathic membranous nephropathy: an autoimmune disease. Semin Nephrol 31(4):333\u2013340. https:\/\/doi.org\/10.1016\/j.semnephrol.2011.06.004","journal-title":"Semin Nephrol"},{"issue":"1","key":"5100_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-021-02421-y","volume":"22","author":"T Tu","year":"2021","unstructured":"Tu T et al (2021) Deep learning-based framework for the distinction of membranous nephropathy: a new approach through hyperspectral imagery. BMC Nephrol 22(1):231. https:\/\/doi.org\/10.1186\/s12882-021-02421-y","journal-title":"BMC Nephrol"},{"key":"5100_CR6","doi-asserted-by":"publisher","unstructured":"Zhang F et al (2023) A case of lupus nephritis preceded by minimal change disease and membranous glomerulonephritis. Am J Case Rep. https:\/\/doi.org\/10.12659\/AJCR.938402","DOI":"10.12659\/AJCR.938402"},{"issue":"6","key":"5100_CR7","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1681\/ASN.2018080852","volume":"30","author":"S Sethi","year":"2019","unstructured":"Sethi S et al (2019) Exostosin 1\/Exostosin 2\u2013associated membranous nephropathy. J Am Soc Nephrol 30(6):1123\u20131136. https:\/\/doi.org\/10.1681\/ASN.2018080852","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"5100_CR8","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/s42003-025-07816-3","volume":"8","author":"X Duan","year":"2025","unstructured":"Duan X et al (2025) Impact of immune cell metabolism on membranous nephropathy and prospective therapy. Commun Biol 8(1):405. https:\/\/doi.org\/10.1038\/s42003-025-07816-3","journal-title":"Commun Biol"},{"issue":"1","key":"5100_CR9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00005-022-00660-x","volume":"70","author":"M Szymczak","year":"2022","unstructured":"Szymczak M et al (2022) Angiotensin II type 1 receptor antibodies are higher in Lupus nephritis and vasculitis than other glomerulonephritis patients. Arch Immunol Ther Exp (Warsz) 70(1):23. https:\/\/doi.org\/10.1007\/s00005-022-00660-x","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"issue":"5","key":"5100_CR10","doi-asserted-by":"publisher","first-page":"705","DOI":"10.23876\/j.krcp.23.286","volume":"44","author":"W Wang","year":"2025","unstructured":"Wang W et al (2025) Donor-derived cell-free DNA-based liquid biopsies to determine future kidney transplant rejection. Kidney Res Clin Pract 44(5):705\u2013725. https:\/\/doi.org\/10.23876\/j.krcp.23.286","journal-title":"Kidney Res Clin Pract"},{"issue":"3","key":"5100_CR11","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1097\/MNH.0000000000000783","volume":"31","author":"D Santoriello","year":"2022","unstructured":"Santoriello D, Nasr SH (2022) Novel approaches beyond standard immunofluorescence for kidney biopsies. Curr Opin Nephrol Hypertens 31(3):221\u2013227. https:\/\/doi.org\/10.1097\/MNH.0000000000000783","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"3","key":"5100_CR12","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s10157-021-02147-z","volume":"26","author":"P Lan","year":"2022","unstructured":"Lan P et al (2022) Evaluation of ultrastructural alterations of glomerular basement membrane and podocytes in glomeruli by low-vacuum scanning electron microscopy. Clin Exp Nephrol 26(3):216\u2013225. https:\/\/doi.org\/10.1007\/s10157-021-02147-z","journal-title":"Clin Exp Nephrol"},{"issue":"5","key":"5100_CR13","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.jfma.2018.12.026","volume":"118","author":"JN Chi","year":"2019","unstructured":"Chi JN et al (2019) The relationship of anti-phospholipase A2 receptor antibody and C5a complement with disease activity and short-term outcome in idiopathic membranous nephropathy. J Formos Med Assoc 118(5):898\u2013906. https:\/\/doi.org\/10.1016\/j.jfma.2018.12.026","journal-title":"J Formos Med Assoc"},{"issue":"1","key":"5100_CR14","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1080\/0886022X.2022.2068442","volume":"44","author":"Y Sun","year":"2022","unstructured":"Sun Y et al (2022) Analysis of glomerular PLA2R efficacy in evaluating the prognosis of Idiopathic Membranous Nephropathy in the background of different serum anti-PLA2R levels. Ren Fail 44(1):731-zz740. https:\/\/doi.org\/10.1080\/0886022X.2022.2068442","journal-title":"Ren Fail"},{"issue":"2","key":"5100_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0298269","volume":"19","author":"X Liu","year":"2024","unstructured":"Liu X et al (2024) Quantitative detection and prognostic value of antibodies against M-type phospholipase A2 receptor and its cysteine-rich ricin domain and C-type lectin domains 1 and 6-7-8 in patients with idiopathic membranous nephropathy. PLoS ONE 19(2):e0298269. https:\/\/doi.org\/10.1371\/journal.pone.0298269","journal-title":"PLoS ONE"},{"issue":"1","key":"5100_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-43766-8","volume":"13","author":"H Zhang","year":"2023","unstructured":"Zhang H, Zhu Y, Hu Z, Liu Q (2023) Serum anti-phospholipase A2 receptor antibody in pathological diagnosis of type 2 diabetes mellitus patients with proteinuria. Sci Rep 13(1):16608. https:\/\/doi.org\/10.1038\/s41598-023-43766-8","journal-title":"Sci Rep"},{"issue":"1","key":"5100_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-023-03190-6","volume":"24","author":"T Matsuzaki","year":"2023","unstructured":"Matsuzaki T, Watanabe Y, Tanaka A, Furuhashi K, Saito S, Maruyama S (2023) Prognosis and incidence of infections in chronic kidney disease patients with membranous nephropathy enrolled in a large Japanese clinical claims database. BMC Nephrol 24(1):126. https:\/\/doi.org\/10.1186\/s12882-023-03190-6","journal-title":"BMC Nephrol"},{"issue":"2","key":"5100_CR18","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1053\/j.ackd.2013.12.002","volume":"21","author":"Y Caliskan","year":"2014","unstructured":"Caliskan Y, Kiryluk K (2014) Novel biomarkers in glomerular disease. Adv Chronic Kidney Dis 21(2):205\u2013216. https:\/\/doi.org\/10.1053\/j.ackd.2013.12.002","journal-title":"Adv Chronic Kidney Dis"},{"issue":"10","key":"5100_CR19","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/s41573-021-00242-0","volume":"20","author":"IS Daehn","year":"2021","unstructured":"Daehn IS, Duffield JS (2021) The glomerular filtration barrier: a structural target for novel kidney therapies. Nat Rev Drug Discov 20(10):770\u2013788. https:\/\/doi.org\/10.1038\/s41573-021-00242-0","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"5100_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33748-1","volume":"13","author":"MK Kocylowski","year":"2022","unstructured":"Kocylowski MK et al (2022) A slit-diaphragm-associated protein network for dynamic control of renal filtration. Nat Commun 13(1):6446. https:\/\/doi.org\/10.1038\/s41467-022-33748-1","journal-title":"Nat Commun"},{"issue":"8","key":"5100_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0104936","volume":"9","author":"Y Du","year":"2014","unstructured":"Du Y et al (2014) The diagnosis accuracy of PLA2R-AB in the diagnosis of idiopathic membranous nephropathy: a meta-analysis. PLoS ONE 9(8):e104936. https:\/\/doi.org\/10.1371\/journal.pone.0104936","journal-title":"PLoS ONE"},{"key":"5100_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1335936","author":"H Jiang","year":"2024","unstructured":"Jiang H et al (2024) Understanding the podocyte immune responses in proteinuric kidney diseases: from pathogenesis to therapy. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2023.1335936","journal-title":"Front Immunol"},{"key":"5100_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.907108","author":"Y-N Wang","year":"2022","unstructured":"Wang Y-N et al (2022) Recent advances in clinical diagnosis and pharmacotherapy options of Membranous Nephropathy. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2022.907108","journal-title":"Front Pharmacol"},{"key":"5100_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1412826","author":"Y Pan","year":"2024","unstructured":"Pan Y et al (2024) Animal models of Membranous Nephropathy: more choices and higher similarity. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2024.1412826","journal-title":"Front Immunol"},{"key":"5100_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01846","author":"W Liu","year":"2020","unstructured":"Liu W et al (2020) Idiopathic Membranous Nephropathy: glomerular pathological pattern caused by extrarenal immunity activity. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2020.01846","journal-title":"Front Immunol"},{"issue":"3","key":"5100_CR26","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.kint.2025.05.025","volume":"108","author":"TN Caza","year":"2025","unstructured":"Caza TN et al (2025) Detection and characterization of NELL1 autoantibodies in NELL1 positive membranous nephropathy. Kidney Int 108(3):427\u2013432. https:\/\/doi.org\/10.1016\/j.kint.2025.05.025","journal-title":"Kidney Int"},{"key":"5100_CR27","doi-asserted-by":"publisher","DOI":"10.3892\/or.2018.6732","author":"I Peters","year":"2018","unstructured":"Peters I et al (2018) DNA methylation of neural EGFL like-1 (NELL1) is associated with advanced disease and the metastatic state of renal cell cancer patients. Oncol Rep. https:\/\/doi.org\/10.3892\/or.2018.6732","journal-title":"Oncol Rep"},{"key":"5100_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcp.2025.102044","volume":"83","author":"CG Haider","year":"2025","unstructured":"Haider CG et al (2025) Copy number variations in urine cell-free DNA from bladder neoplasm patients. Mol Cell Probes 83:102044. https:\/\/doi.org\/10.1016\/j.mcp.2025.102044","journal-title":"Mol Cell Probes"},{"issue":"3","key":"5100_CR29","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.identj.2023.10.017","volume":"74","author":"Y Wang","year":"2024","unstructured":"Wang Y et al (2024) Exostoisns (EXT1\/2) in head and neck cancers: An in silico analysis and clinical correlates. Int Dent J 74(3):446\u2013453. https:\/\/doi.org\/10.1016\/j.identj.2023.10.017","journal-title":"Int Dent J"},{"key":"5100_CR30","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2025.2458681","author":"J Ling","year":"2025","unstructured":"Ling J et al (2025) Dual roles of exostosin glycosyltransferase 1 in Zika virus infection. Virulence. https:\/\/doi.org\/10.1080\/21505594.2025.2458681","journal-title":"Virulence"},{"key":"5100_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.593288","author":"V Tesar","year":"2021","unstructured":"Tesar V, Hruskova Z (2021) Autoantibodies in the diagnosis, monitoring, and treatment of Membranous Nephropathy. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2021.593288","journal-title":"Front Immunol"},{"issue":"9","key":"5100_CR32","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.2215\/CJN.02170312","volume":"7","author":"C Murtas","year":"2012","unstructured":"Murtas C et al (2012) Coexistence of different circulating anti-podocyte antibodies in membranous nephropathy. Clin J Am Soc Nephrol 7(9):1394\u20131400. https:\/\/doi.org\/10.2215\/CJN.02170312","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"5100_CR33","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1681\/ASN.2015101170","volume":"27","author":"H Debiec","year":"2016","unstructured":"Debiec H, Ronco P (2016) Immune response against autoantigen PLA2R is not gambling: Implications for pathophysiology, prognosis, and therapy. J Am Soc Nephrol 27(5):1275\u20131277. https:\/\/doi.org\/10.1681\/ASN.2015101170","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"5100_CR34","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1093\/ndt\/gfad227","volume":"39","author":"S Sethi","year":"2024","unstructured":"Sethi S, Fervenza FC (2024) Membranous nephropathy\u2014diagnosis and identification of target antigens. Nephrol Dial Transpl 39(4):600\u2013606. https:\/\/doi.org\/10.1093\/ndt\/gfad227","journal-title":"Nephrol Dial Transpl"},{"issue":"3","key":"5100_CR35","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.kint.2023.01.001","volume":"103","author":"TN Caza","year":"2023","unstructured":"Caza TN et al (2023) Discovery of seven novel putative antigens in membranous nephropathy and membranous Lupus nephritis identified by mass spectrometry. Kidney Int 103(3):593\u2013606. https:\/\/doi.org\/10.1016\/j.kint.2023.01.001","journal-title":"Kidney Int"},{"issue":"10","key":"5100_CR36","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/s41581-025-00980-z","volume":"21","author":"S Sethi","year":"2025","unstructured":"Sethi S, Fervenza FC (2025) Antigens in membranous nephropathy: discovery and clinical implications. Nat Rev Nephrol 21(10):653\u2013670. https:\/\/doi.org\/10.1038\/s41581-025-00980-z","journal-title":"Nat Rev Nephrol"},{"key":"5100_CR37","doi-asserted-by":"publisher","DOI":"10.1177\/11772719241259602","author":"T Dhaouadi","year":"2024","unstructured":"Dhaouadi T, Riahi A, Ben Abdallah T, Gorgi Y, Sfar I (2024) Association of 10 polymorphisms in PLA2R1 and HLA DQA1 genes with Primary Membranous Nephropathy risk: a meta-analysis and a meta-regression. Biomark Insights. https:\/\/doi.org\/10.1177\/11772719241259602","journal-title":"Biomark Insights"},{"issue":"1","key":"5100_CR38","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s40620-023-01804-8","volume":"37","author":"J Jefferis","year":"2023","unstructured":"Jefferis J et al (2023) Monogenic and polygenic concepts in chronic kidney disease (CKD). J Nephrol 37(1):7\u201321. https:\/\/doi.org\/10.1007\/s40620-023-01804-8","journal-title":"J Nephrol"},{"key":"5100_CR39","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfae069.130","author":"S Montagner","year":"2024","unstructured":"Montagner S et al (2024) #2086 understanding B cell memory autoreactivity in Idiopathic Membranous Nephropathy for tailored therapy. Nephrol Dial Transpl. https:\/\/doi.org\/10.1093\/ndt\/gfae069.130","journal-title":"Nephrol Dial Transpl"},{"issue":"9","key":"5100_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19095301","volume":"19","author":"I Smarz-Widelska","year":"2022","unstructured":"Smarz-Widelska I, Choj\u0119ta D, Kozio\u0142 MM (2022) The role of Anti-PLA2R and Anti-THSD7A antibodies in the pathogenesis and diagnostics of primary membranous nephropathy: A review of current knowledge for clinical practice. Int J Environ Res Public Health 19(9):5301. https:\/\/doi.org\/10.3390\/ijerph19095301","journal-title":"Int J Environ Res Public Health"},{"issue":"8","key":"5100_CR41","doi-asserted-by":"publisher","first-page":"889","DOI":"10.17219\/acem\/189865","volume":"33","author":"L Deng","year":"2024","unstructured":"Deng L et al (2024) Expansion of T follicular helper cells is associated with disease progression in rat experimental membranous nephropathy model. Adv Clin Exp Med 33(8):889\u2013899. https:\/\/doi.org\/10.17219\/acem\/189865","journal-title":"Adv Clin Exp Med"},{"issue":"7","key":"5100_CR42","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1007\/s12098-023-04815-2","volume":"91","author":"L Xu","year":"2024","unstructured":"Xu L, Tayier D, Yang S, Zhang X, Lu C (2024) Follicular helper T cells and follicular regulatory T cells involved in immune disorders of idiopathic membranous nephropathy. Indian J Pediatr 91(7):702\u2013708. https:\/\/doi.org\/10.1007\/s12098-023-04815-2","journal-title":"Indian J Pediatr"},{"key":"5100_CR43","doi-asserted-by":"publisher","unstructured":"Sevinc M et al (2025) Kinetics of CD19+ B-cell depletion post-rituximab in membranous nephropathy. Clin Kidney J. https:\/\/doi.org\/10.1093\/ckj\/sfaf153","DOI":"10.1093\/ckj\/sfaf153"},{"key":"5100_CR44","doi-asserted-by":"publisher","unstructured":"Lu F et al (2025) Exploring immunological alterations of B cells in peripheral immunity via single-cell RNA sequencing: insights into primary membranous nephropathy. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2025.1622395.","DOI":"10.3389\/fimmu.2025.1622395"},{"key":"5100_CR45","doi-asserted-by":"publisher","unstructured":"Rojas-Rivera JE, Ortiz Ardu\u00e1n A (2021) Primary membranous nephropathy in the era of autoantibodies and biological therapies. Medicina Cl\u00ednica (English Edition) 157(3):121\u2013129. https:\/\/doi.org\/10.1016\/j.medcle.2021.02.004","DOI":"10.1016\/j.medcle.2021.02.004"},{"issue":"2","key":"5100_CR46","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s00441-021-03429-4","volume":"385","author":"NM Tomas","year":"2021","unstructured":"Tomas NM, Huber TB, Hoxha E (2021) Perspectives in membranous nephropathy. Cell Tissue Res 385(2):405\u2013422. https:\/\/doi.org\/10.1007\/s00441-021-03429-4","journal-title":"Cell Tissue Res"},{"issue":"5","key":"5100_CR47","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1681\/ASN.2014111061","volume":"27","author":"B Seitz-Polski","year":"2016","unstructured":"Seitz-Polski B et al (2016) Epitope spreading of autoantibody response to PLA2R associates with poor prognosis in membranous nephropathy. J Am Soc Nephrol 27(5):1517\u20131533. https:\/\/doi.org\/10.1681\/ASN.2014111061","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"5100_CR48","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1681\/ASN.2016020114","volume":"28","author":"Z Cui","year":"2017","unstructured":"Cui Z et al (2017) MHC Class II risk alleles and amino acid residues in idiopathic membranous nephropathy. J Am Soc Nephrol 28(5):1651\u20131664. https:\/\/doi.org\/10.1681\/ASN.2016020114","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"5100_CR49","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.kint.2022.11.021","volume":"103","author":"X Zhang","year":"2023","unstructured":"Zhang X et al (2023) Mapping the T cell epitopes of the M-type transmembrane phospholipase A2 receptor in primary membranous nephropathy. Kidney Int 103(3):580\u2013592. https:\/\/doi.org\/10.1016\/j.kint.2022.11.021","journal-title":"Kidney Int"},{"key":"5100_CR50","doi-asserted-by":"publisher","unstructured":"Koneczny I et al (2021) Common denominators in the immunobiology of IgG4 autoimmune diseases: what do glomerulonephritis, pemphigus vulgaris, myasthenia gravis, thrombotic thrombocytopenic purpura and autoimmune encephalitis have in common? Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2020.605214","DOI":"10.3389\/fimmu.2020.605214"},{"issue":"1","key":"5100_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-021-00969-0","volume":"14","author":"S Fan","year":"2021","unstructured":"Fan S et al (2021) The association between variants in PLA2R and HLA-DQA1 and renal outcomes in patients with primary membranous nephropathy in Western China. BMC Med Genomics 14(1):123. https:\/\/doi.org\/10.1186\/s12920-021-00969-0","journal-title":"BMC Med Genomics"},{"issue":"1","key":"5100_CR52","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1097\/MNH.0000000000000459","volume":"28","author":"DJ Salant","year":"2019","unstructured":"Salant DJ (2019) Unmet challenges in membranous nephropathy. Curr Opin Nephrol Hypertens 28(1):70\u201376. https:\/\/doi.org\/10.1097\/MNH.0000000000000459","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"5100_CR53","doi-asserted-by":"publisher","unstructured":"Tomas NM (2024) Therapeutic targets in membranous nephropathy: plasma cells and complement. Clin Kidney J. https:\/\/doi.org\/10.1093\/ckj\/sfae243","DOI":"10.1093\/ckj\/sfae243"},{"key":"5100_CR54","doi-asserted-by":"publisher","unstructured":"Haddad G et al (2021) Altered glycosylation of IgG4 promotes lectin complement pathway activation in anti-PLA2R1\u2013associated membranous nephropathy. J Clin Investig. https:\/\/doi.org\/10.1172\/JCI140453","DOI":"10.1172\/JCI140453"},{"issue":"1","key":"5100_CR55","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ekir.2022.10.008","volume":"8","author":"M Teisseyre","year":"2023","unstructured":"Teisseyre M et al (2023) C5b-9 glomerular deposits are associated with poor renal survival in membranous nephropathy. Kidney Int Rep 8(1):103\u2013114. https:\/\/doi.org\/10.1016\/j.ekir.2022.10.008","journal-title":"Kidney Int Rep"},{"issue":"1","key":"5100_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-46026-x","volume":"13","author":"RM Muts","year":"2023","unstructured":"Muts RM et al (2023) Artificial surface labelling of Escherichia coli with StrepTagII antigen to study how monoclonal antibodies drive complement-mediated killing. Sci Rep 13(1):18836. https:\/\/doi.org\/10.1038\/s41598-023-46026-x","journal-title":"Sci Rep"},{"key":"5100_CR57","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.2147\/IJGM.S407073","volume":"16","author":"J Li","year":"2023","unstructured":"Li J et al (2023) Lectin complement pathway activation is associated with massive proteinuria in PLA2R-positive membranous nephropathy: a retrospective study. Int J Gen Med 16:1879\u20131889. https:\/\/doi.org\/10.2147\/IJGM.S407073","journal-title":"Int J Gen Med"},{"key":"5100_CR58","doi-asserted-by":"publisher","unstructured":"So BYF, Chan GCW, Yap DYH, Chan TM (2022) The role of the complement system in primary membranous nephropathy: A narrative review in the era of new therapeutic targets. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2022.1009864","DOI":"10.3389\/fimmu.2022.1009864"},{"issue":"9","key":"5100_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23094664","volume":"23","author":"C Chinello","year":"2022","unstructured":"Chinello C et al (2022) Definition of IgG subclass-specific glycopatterns in idiopathic membranous nephropathy: aberrant IgG glycoforms in blood. Int J Mol Sci 23(9):4664. https:\/\/doi.org\/10.3390\/ijms23094664","journal-title":"Int J Mol Sci"},{"issue":"2","key":"5100_CR60","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00441-021-03433-8","volume":"385","author":"F Demir","year":"2021","unstructured":"Demir F et al (2021) Proteolysis and inflammation of the kidney glomerulus. Cell Tissue Res 385(2):489\u2013500. https:\/\/doi.org\/10.1007\/s00441-021-03433-8","journal-title":"Cell Tissue Res"},{"issue":"3","key":"5100_CR61","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1681\/ASN.0000000000000068","volume":"34","author":"L Reinhard","year":"2023","unstructured":"Reinhard L et al (2023) Pathogenicity of human anti-PLA2R1 antibodies in minipigs: a pilot study. J Am Soc Nephrol 34(3):369\u2013373. https:\/\/doi.org\/10.1681\/ASN.0000000000000068","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"5100_CR62","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1681\/ASN.2019030273","volume":"31","author":"L Reinhard","year":"2020","unstructured":"Reinhard L, Zahner G, Menzel S, Koch-Nolte F, Stahl RAK, Hoxha E (2020) Clinical relevance of domain-specific phospholipase A2 receptor 1 antibody levels in patients with membranous nephropathy. J Am Soc Nephrol 31(1):197\u2013207. https:\/\/doi.org\/10.1681\/ASN.2019030273","journal-title":"J Am Soc Nephrol"},{"key":"5100_CR63","doi-asserted-by":"publisher","unstructured":"Cravedi P, Jarque M, Angeletti A, Fav\u00e0 \u00c0, Cantarelli C, Bestard O (2019) Immune-monitoring disease activity in primary membranous nephropathy. Front Med (Lausanne). https:\/\/doi.org\/10.3389\/fmed.2019.00241","DOI":"10.3389\/fmed.2019.00241"},{"issue":"1","key":"5100_CR64","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13010068","volume":"13","author":"X Hu","year":"2023","unstructured":"Hu X et al (2023) The role of renal PLA2R staining combined with serum PLA2R antibody in membranous nephropathy risk stratification. J Clin Med 13(1):68. https:\/\/doi.org\/10.3390\/jcm13010068","journal-title":"J Clin Med"},{"issue":"4","key":"5100_CR65","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2022-002907","volume":"9","author":"U Blache","year":"2023","unstructured":"Blache U, Tretbar S, Koehl U, Mougiakakos D, Fricke S (2023) CAR T cells for treating autoimmune diseases. RMD Open 9(4):e002907. https:\/\/doi.org\/10.1136\/rmdopen-2022-002907","journal-title":"RMD Open"},{"key":"5100_CR66","doi-asserted-by":"publisher","unstructured":"Cheng YJ, Wang M, Wang J, Cui Z, Zhao MH (2023) The characters of antibodies against PLA2R in healthy individuals and in the patient with PLA2R associated membranous nephropathy. Eur J Med Res 28(1):128. https:\/\/doi.org\/10.1186\/s40001-023-01096-5","DOI":"10.1186\/s40001-023-01096-5"},{"key":"5100_CR67","doi-asserted-by":"publisher","DOI":"10.3390\/biom11040513","author":"Y Gui","year":"2021","unstructured":"Gui Y, Xu H, Tang D (2021) Mechanisms of primary Membranous Nephropathy. Biomolecules. https:\/\/doi.org\/10.3390\/biom11040513","journal-title":"Biomolecules"},{"key":"5100_CR68","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1382977","author":"Z Chen","year":"2024","unstructured":"Chen Z, Xu Q, Shou Z (2024) Application of CD38 monoclonal antibody in kidney disease. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2024.1382977","journal-title":"Front Immunol"},{"key":"5100_CR69","doi-asserted-by":"publisher","DOI":"10.3389\/fneph.2025.1548679","author":"B Mao","year":"2025","unstructured":"Mao B, Han J, Wang J, Ye K (2025) Efficacy and safety of rituximab for Membranous Nephropathy in adults: a meta-analysis of RCT. Front Nephrol. https:\/\/doi.org\/10.3389\/fneph.2025.1548679","journal-title":"Front Nephrol"},{"issue":"8","key":"5100_CR70","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.2215\/CJN.11791018","volume":"14","author":"B Seitz-Polski","year":"2019","unstructured":"Seitz-Polski B et al (2019) High-dose rituximab and early remission in PLA2R1-related membranous nephropathy. Clin J Am Soc Nephrol 14(8):1173\u20131182. https:\/\/doi.org\/10.2215\/CJN.11791018","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"5100_CR71","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1681\/ASN.2017070734","volume":"29","author":"B Seitz-Polski","year":"2018","unstructured":"Seitz-Polski B et al (2018) Phospholipase A2 receptor 1 epitope spreading at baseline predicts reduced likelihood of remission of membranous nephropathy. J Am Soc Nephrol 29(2):401\u2013408. https:\/\/doi.org\/10.1681\/ASN.2017070734","journal-title":"J Am Soc Nephrol"},{"key":"5100_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2025.120162","volume":"569","author":"Z Zhang","year":"2025","unstructured":"Zhang Z et al (2025) Diagnostic value of three urine miRNAs composite score in BK virus nephropathy. Clin Chim Acta 569:120162. https:\/\/doi.org\/10.1016\/j.cca.2025.120162","journal-title":"Clin Chim Acta"},{"issue":"5","key":"5100_CR73","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0302100","volume":"19","author":"K Zhou","year":"2024","unstructured":"Zhou K et al (2024) Predictive value of the domain specific PLA2R antibodies for clinical remission in patients with primary membranous nephropathy: A retrospective study. PLoS ONE 19(5):e0302100. https:\/\/doi.org\/10.1371\/journal.pone.0302100","journal-title":"PLoS ONE"},{"key":"5100_CR74","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2018.33.e74","author":"J-Y Choi","year":"2018","unstructured":"Choi J-Y et al (2018) The effect of Mycophenolate Mofetil versus Cyclosporine as combination therapy with low dose corticosteroids in high-risk patients with Idiopathic Membranous Nephropathy: a multicenter randomized trial. J Korean Med Sci. https:\/\/doi.org\/10.3346\/jkms.2018.33.e74","journal-title":"J Korean Med Sci"},{"issue":"9","key":"5100_CR75","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1016\/j.ekir.2023.06.001","volume":"8","author":"R Benyahia","year":"2023","unstructured":"Benyahia R et al (2023) Membranous nephropathy after exposure to immune checkpoint inhibitors. Kidney Int Rep 8(9):1892\u20131898. https:\/\/doi.org\/10.1016\/j.ekir.2023.06.001","journal-title":"Kidney Int Rep"},{"key":"5100_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/1324804","volume":"2019","author":"M Lateb","year":"2019","unstructured":"Lateb M et al (2019) Anti-PLA2R1 antibodies containing sera induce in vitro cytotoxicity mediated by complement activation. J Immunol Res 2019:1\u201314. https:\/\/doi.org\/10.1155\/2019\/1324804","journal-title":"J Immunol Res"},{"key":"5100_CR77","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.800242","author":"TN Caza","year":"2021","unstructured":"Caza TN, Al-Rabadi LF, Beck LH (2021) How times have changed! A cornucopia of antigens for Membranous Nephropathy. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2021.800242","journal-title":"Front Immunol"},{"issue":"1","key":"5100_CR78","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa0810457","volume":"361","author":"LH Beck","year":"2009","unstructured":"Beck LH et al (2009) M-type phospholipase A 2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 361(1):11\u201321. https:\/\/doi.org\/10.1056\/NEJMoa0810457","journal-title":"N Engl J Med"},{"issue":"24","key":"5100_CR79","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1056\/NEJMoa1409354","volume":"371","author":"NM Tomas","year":"2014","unstructured":"Tomas NM et al (2014) Thrombospondin Type-1 domain-containing 7A in idiopathic membranous nephropathy. N Engl J Med 371(24):2277\u20132287. https:\/\/doi.org\/10.1056\/NEJMoa1409354","journal-title":"N Engl J Med"},{"issue":"1","key":"5100_CR80","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.kint.2019.09.014","volume":"97","author":"S Sethi","year":"2020","unstructured":"Sethi S et al (2020) Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy. Kidney Int 97(1):163\u2013174. https:\/\/doi.org\/10.1016\/j.kint.2019.09.014","journal-title":"Kidney Int"},{"issue":"1","key":"5100_CR81","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.kint.2020.09.016","volume":"100","author":"TN Caza","year":"2021","unstructured":"Caza TN et al (2021) Neural cell adhesion molecule 1 is a novel autoantigen in membranous lupus nephritis. Kidney Int 100(1):171\u2013181. https:\/\/doi.org\/10.1016\/j.kint.2020.09.016","journal-title":"Kidney Int"},{"issue":"5","key":"5100_CR82","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/j.kint.2020.05.030","volume":"98","author":"S Sethi","year":"2020","unstructured":"Sethi S et al (2020) Semaphorin 3B\u2013associated membranous nephropathy is a distinct type of disease predominantly present in pediatric patients. Kidney Int 98(5):1253\u20131264. https:\/\/doi.org\/10.1016\/j.kint.2020.05.030","journal-title":"Kidney Int"},{"key":"5100_CR83","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.759187","author":"Q Xu","year":"2021","unstructured":"Xu Q et al (2021) Characteristics of Anti-Contactin1 antibody-associated Autoimmune Nodopathies with concomitant Membranous Nephropathy. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2021.759187","journal-title":"Front Immunol"},{"issue":"5","key":"5100_CR84","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1681\/ASN.2021111488","volume":"33","author":"S Sethi","year":"2022","unstructured":"Sethi S et al (2022) Hematopoietic stem cell transplant-membranous nephropathy is associated with protocadherin FAT1. J Am Soc Nephrol 33(5):1033\u20131044. https:\/\/doi.org\/10.1681\/ASN.2021111488","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"5100_CR85","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1681\/ASN.2020081165","volume":"32","author":"S Sethi","year":"2021","unstructured":"Sethi S et al (2021) Protocadherin 7\u2013associated membranous nephropathy. J Am Soc Nephrol 32(5):1249\u20131261. https:\/\/doi.org\/10.1681\/ASN.2020081165","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"5100_CR86","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2202-11-137","volume":"11","author":"X-L Kuang","year":"2010","unstructured":"Kuang X-L, Zhao X-M, Xu H-F, Shi Y-Y, Deng J-B, Sun G-T (2010) Spatio-temporal expression of a novel neuron-derived neurotrophic factor (NDNF) in mouse brains during development. BMC Neurosci 11(1):137. https:\/\/doi.org\/10.1186\/1471-2202-11-137","journal-title":"BMC Neurosci"},{"issue":"2","key":"5100_CR87","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.kint.2023.04.006","volume":"104","author":"S Sethi","year":"2023","unstructured":"Sethi S et al (2023) Proprotein convertase subtilisin\/kexin type 6 (PCSK6) is a likely antigenic target in membranous nephropathy and nonsteroidal anti-inflammatory drug use. Kidney Int 104(2):343\u2013352. https:\/\/doi.org\/10.1016\/j.kint.2023.04.006","journal-title":"Kidney Int"},{"issue":"7","key":"5100_CR88","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1681\/ASN.2020101395","volume":"32","author":"LF Al-Rabadi","year":"2021","unstructured":"Al-Rabadi LF et al (2021) Serine protease HTRA1 as a novel target antigen in primary membranous nephropathy. J Am Soc Nephrol 32(7):1666\u20131681. https:\/\/doi.org\/10.1681\/ASN.2020101395","journal-title":"J Am Soc Nephrol"},{"issue":"20","key":"5100_CR89","doi-asserted-by":"publisher","first-page":"8244","DOI":"10.1074\/jbc.M117.775031","volume":"292","author":"I Grishkovskaya","year":"2017","unstructured":"Grishkovskaya I et al (2017) Structure of human promyeloperoxidase (proMPO) and the role of the propeptide in processing and maturation. J Biol Chem 292(20):8244\u20138261. https:\/\/doi.org\/10.1074\/jbc.M117.775031","journal-title":"J Biol Chem"},{"issue":"8","key":"5100_CR90","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1091\/mbc.11.8.2657","volume":"11","author":"JM Wilson","year":"2000","unstructured":"Wilson JM, de Hoop M, Zorzi N, Toh B-H, Dotti CG, Parton RG (2000) EEA1, a tethering protein of the early sorting endosome, shows a polarized distribution in hippocampal neurons, epithelial cells, and fibroblasts. Mol Biol Cell 11(8):2657\u20132671. https:\/\/doi.org\/10.1091\/mbc.11.8.2657","journal-title":"Mol Biol Cell"},{"issue":"26","key":"5100_CR91","doi-asserted-by":"publisher","first-page":"9611","DOI":"10.1523\/JNEUROSCI.0035-11.2011","volume":"31","author":"L Xiao","year":"2011","unstructured":"Xiao L et al (2011) The c-Abl-MST1 signaling pathway mediates oxidative stress-induced neuronal cell death. J Neurosci 31(26):9611\u20139619. https:\/\/doi.org\/10.1523\/JNEUROSCI.0035-11.2011","journal-title":"J Neurosci"},{"key":"5100_CR92","doi-asserted-by":"publisher","unstructured":"Ohgidani M et al (2017) Microglial CD206 gene has potential as a state marker of bipolar disorder. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2016.00676","DOI":"10.3389\/fimmu.2016.00676"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05100-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-026-05100-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05100-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T07:53:12Z","timestamp":1789631592000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-026-05100-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":92,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["5100"],"URL":"https:\/\/doi.org\/10.1007\/s11255-026-05100-9","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]},"assertion":[{"value":"30 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}